Ads
related to: merck- Cell Therapy Production
Cell Therapy Manufacturing Services
From Clinical To Commercial
- AAV Reference Standards
Essential AAV Reference Standards
Full & Empty Capsids of 6 Serotypes
- GMP Retrovirus Services
cGMP-compliant & fully scalable
Viral vector manufacturing
- GMP QC Services
Viral Vector & Plasmid Assays
Quality, Sterility & Potency
- Cell Therapy Production
Search results
Merck (MRK) to Buy Private Ophthalmology Company EyeBio
Zacks via Yahoo Finance· 23 hours agoMerck's (MRK) acquisition of EyeBio is set to add the latter's lead pipeline candidate, Restoret, a...
Dow Jones Rises On Inflation Data; Dell Plunges 19% On Earnings
Investor's Business Daily· 2 hours agoStock Market Today: Best Stocks To Watch Birkenstock, Netflix, Robinhood Markets and TJX — plus Dow...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 2 hours agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 2 days agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
Germany's Merck, Korean science institute set up R&D partnership
dpa international via Yahoo News· 1 day agoGerman science and technology major Merck and the Korea Advanced Institute of Science and Technology...
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Market Watch· 19 hours agojumped more than 270% Thursday after the company said its experimental cancer drug outperformed ...
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 3 days agoEditor’s Note: The title of the story is updated to correct the reference to ‘Breast’ cancer instead...
Summit Shares Soar After Cancer Drug Tops Merck’s Keytruda
Bloomberg via Yahoo Finance· 19 hours ago(Bloomberg) -- Summit Therapeutics Inc. shares jumped after the biotech company said a late-stage...
Merck to Acquire EyeBio
Morningstar· 2 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today ...
Competitor to Merck's Keytruda Worries Some Investors
Barrons.com· 20 hours agoInvestors in Merck don't seem pleased with a competitor cancer-treatment candidate outperforming...